Loading clinical trials...
Loading clinical trials...
Phase IV Study for Evaluation the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain
Conditions
Interventions
Smilon®
Placebo
Locations
1
Taiwan
Nang Kuang Pharmaceutical Co., LTD
Tainan, Xinhua Township, Taiwan
Start Date
December 1, 2009
Primary Completion Date
August 1, 2010
Completion Date
November 1, 2010
Last Updated
June 9, 2011
NCT06346132
NCT07360600
NCT07351968
NCT06793397
NCT07482709
NCT06946290
Lead Sponsor
Nang Kuang Pharmaceutical Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions